|
NXU.X |
NXU 24-02-29 Q2 Quarterly Report |
Déclaration d'inscription trimestrielle |
25/04/2024 |
 Open Filing (1.24 Mo) |
|
PERK |
FORM 9 NOTICE OF PROPOSED ISSUANCE OF LISTED SECURITIES |
Émission proposée des titres cotés |
25/04/2024 |
Open Filing (168.85 Ko) |
|
PERK |
Perk Labs Announces Closing of Non-Brokered Private Placements |
Communiqué de presse |
25/04/2024 |
Open Filing (140.89 Ko) |
|
OMGA |
Certificate of Compliance |
Certificat de conformité |
25/04/2024 |
Open Filing (313.19 Ko) |
|
OMGA |
Cover Letter |
Lettre de motivation |
25/04/2024 |
Open Filing (291.55 Ko) |
|
ORGN |
Notice of Proposed Stock Option Grant or Amendment |
Proposition d'options d'achat |
25/04/2024 |
Open Filing (126.72 Ko) |
|
TCF |
Consent Letter (Oil & Gas Annual Disclosure Filing) |
Autre |
25/04/2024 |
Open Filing (78.93 Ko) |
|
TCF |
Oil & Gas Annual Disclosure Filing (Form 51-101F3) |
Technical Report |
25/04/2024 |
Open Filing (563.49 Ko) |
|
MYCO |
MYDECINE ANNOUNCES INTENTION TO REFILE CERTAIN FINANCIAL STATEMENTS AND APPLIES FOR MANAGEMENT CEASE TRADE ORDER |
Communiqué de presse |
25/04/2024 |
Open Filing (140.55 Ko) |
|
TCF |
Oil & Gas Annual Disclosure Filing (Form 51-101F2) |
Technical Report |
25/04/2024 |
Open Filing (214.02 Ko) |
